KANYOS
Live / Registered — Registered (as of 15 Sept 2020)
What this means for you
Registered since 15 Sept 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87244213
- Registration number
- 6153476
- Mark type
- Stylized text
- Filed
- 21 Nov 2016
- Published for opposition
- 04 Apr 2017
- Registered
- 15 Sept 2020
- Attorney of record
- Jason A. Gersting, Ph.D.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for achieving immune tolerance; Pharmaceutical preparations for reducing immunogenicity using engineered molecules
Owner
- KANYOS BIO, INC., Cambridge, MA, US
- KANYOS BIO, INC., Cambridge, MA, US
- KANYOS BIO, INC., Cambridge, MA, US
Prosecution history
- 15 Sept 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Oct 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 15 Sept 2020 — REGISTERED-PRINCIPAL REGISTER
- 13 Aug 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Aug 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Jul 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Jul 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Jul 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Jan 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Jan 2020 — NON-FINAL ACTION E-MAILED
- 31 Jan 2020 — SU - NON-FINAL ACTION - WRITTEN
- 14 Jan 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Jan 2020 — USE AMENDMENT FILED
- 08 Jan 2020 — TEAS STATEMENT OF USE RECEIVED
- 22 Nov 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED